BE854414A - Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate - Google Patents

Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate

Info

Publication number
BE854414A
BE854414A BE177399A BE177399A BE854414A BE 854414 A BE854414 A BE 854414A BE 177399 A BE177399 A BE 177399A BE 177399 A BE177399 A BE 177399A BE 854414 A BE854414 A BE 854414A
Authority
BE
Belgium
Prior art keywords
prostate
treatment
pharmaceutical compositions
hypertrophia
benign
Prior art date
Application number
BE177399A
Other languages
English (en)
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of BE854414A publication Critical patent/BE854414A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
BE177399A 1976-05-10 1977-05-09 Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate BE854414A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/684,945 US4055641A (en) 1976-05-10 1976-05-10 Method of treating benign prostatic hypertrophy

Publications (1)

Publication Number Publication Date
BE854414A true BE854414A (fr) 1977-09-01

Family

ID=24750167

Family Applications (1)

Application Number Title Priority Date Filing Date
BE177399A BE854414A (fr) 1976-05-10 1977-05-09 Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate

Country Status (4)

Country Link
US (1) US4055641A (fr)
BE (1) BE854414A (fr)
PH (1) PH13959A (fr)
ZA (1) ZA772087B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817157A1 (de) * 1978-04-17 1979-10-25 Schering Ag Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
DE3121153A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
DE3121152A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen "verwendung der kombination eines aromatase-hemmers mit einem antiandrogen zur prophylaxe und therapie der prostatahyperplasie"
US4396615A (en) * 1981-06-24 1983-08-02 Duke University Method of treating androgen-related disorders
DE3380923D1 (de) * 1983-07-29 1990-01-11 Univ Duke Pharmazeutische zusammensetzungen zur behandlung von stoerungen, bedingt durch humanendrogen.
US5595985A (en) * 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
US5364847A (en) * 1989-03-10 1994-11-15 Endorecherche Inhibitors of sex steroid biosynthesis and methods for their production and use
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
ATE230994T1 (de) * 1989-07-07 2003-02-15 Endorech Inc Methode zur behandlung androgenbedingter krankheiten
JP2959839B2 (ja) * 1989-07-07 1999-10-06 アンドルシェルシュ・インコーポレイテッド 性ステロイド活性の抑制における使用のためのアンドロゲン誘導体
US5162624A (en) * 1991-10-11 1992-11-10 Duksa Thomas R Flow switch
SK140494A3 (en) * 1992-05-21 1995-07-11 Endorecherche Inc Inhibitors of testosterone 5-alpha-reductase activity
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US20060079492A1 (en) * 1999-10-25 2006-04-13 Ahlem Clarence N Compositions and treatment methods
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US8562589B2 (en) * 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
US9259386B2 (en) 2010-12-23 2016-02-16 Rani Therapeutics, Llc Therapeutic preparation comprising somatostatin or somatostatin analogoue for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9283179B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc GnRH preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9415004B2 (en) 2010-12-23 2016-08-16 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9284367B2 (en) 2010-12-23 2016-03-15 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US10639272B2 (en) 2010-12-23 2020-05-05 Rani Therapeutics, Llc Methods for delivering etanercept preparations into a lumen of the intestinal tract using a swallowable drug delivery device
US8809269B2 (en) 2010-12-23 2014-08-19 Rani Therapeutics, Llc Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8969293B2 (en) 2010-12-23 2015-03-03 Rani Therapeutics, Llc Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9629799B2 (en) 2010-12-23 2017-04-25 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US8734429B2 (en) 2010-12-23 2014-05-27 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
US9861683B2 (en) 2010-12-23 2018-01-09 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402807B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US9402806B2 (en) 2010-12-23 2016-08-02 Rani Therapeutics, Llc Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449381A (en) * 1962-06-12 1969-06-10 Syntex Corp 19-oxo- and 19-lower alkyl-19-oxoandrostane derivatives
US3235573A (en) * 1962-12-20 1966-02-15 Syntex Corp 19-lower alkylidene and 19-oxo-delta4-androsten-17beta-ol-3-one derivatives

Also Published As

Publication number Publication date
US4055641A (en) 1977-10-25
ZA772087B (en) 1978-06-28
PH13959A (en) 1980-11-12

Similar Documents

Publication Publication Date Title
BE854414A (fr) Compositions pharmaceutiques pour le traitement de l'hypertrophie benigne de la prostate
BE859817A (fr) Compositions notamment utiles pour le traitement de l'acne
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
BE851328A (fr) Composition pour le traitement de l'hypercholesterolemie
BE823345A (fr) Compositions pharmaceutiques pour empecher l'absorption de cholesterol
FR2338687A1 (fr) Endoscope pour le traitement de strictions uretrales
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
BE890648A (fr) Compositions pour le traitement de l'acne
FR2316954A1 (fr) Preparation dentaire pour le traitement de la parodontose
BE865156A (fr) Compositions pharmaceutiques pour le traitement des depressions
BE837662A (fr) Composition gelifiee contenant de la tretinoine pour le traitement de l'acne
BE851775A (fr) Composition pour le traitement de la chevelure
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne
BE829859A (fr) Procedes et compositions pharmaceutiques pour le traitement de l'hypercholesterolemie
BE852095A (fr) Composition pharmaceutique pour le traitement de la leucemie et de tumeurs
BE885291A (fr) Compositions pharmaceutiques pour le traitement des dysfonctionnements cardiaques
BE873092A (fr) Composition pour le traitement de l'hypertension
BE872908A (fr) Compositions pharmaceutiques pour le traitement de l'hypertension
BE858692A (fr) Composition pour le traitement de l'acne
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
FR2310769A1 (fr) Medicament pour le traitement de l'alopecia seborrhoeica
FR2332965A1 (fr) Formulations d'uree-polyphosphate-potassium pour le traitement du feuillage
FR2340737A1 (fr) Composition pour le traitement de l'hypercholesterolemie
BE854412A (fr) Compositions pharmaceutiques pour un traitement gynecologique
BE829024A (fr) Compositions pharmaceutiques pour le traitement de l'hydropisie

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RICHARDSON-MERRELL INC.

Effective date: 19920531